Small molecule · Acts on cytochrome c oxidase (cytochrome a3) and rhodanese (thiosulfate sulfurtransferase) (TST) · developed by Us Army
ApprovedFDA, Feb 1992
1Registered trials
What is Sodium Thiosulfate?
Sodium thiosulfate is an antidote that serves as a sulfur donor for rhodanese, enhancing the conversion of cyanide to thiocyanate, which is relatively nontoxic and readily excreted. It is used with sodium nitrite in acute cyanide poisoning and is also studied for reducing cisplatin-induced ototoxicity in children with solid tumors.
Summary written with AI from the sources listed at the end of this page.
At a glance
Also known as
Pedmark, DB-020, NSC-45624
Drug type
Small molecule
Targets
cytochrome c oxidase (cytochrome a3), rhodanese (thiosulfate sulfurtransferase) (TST)
Mechanism
Acts on cytochrome c oxidase (cytochrome a3) and rhodanese (thiosulfate sulfurtransferase) (TST)
Pathways
cyanide detoxification to thiocyanate, aerobic metabolism restoration
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z
This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.